Abstract
Photophobia is one of the most common visual complaints stemming from mild traumatic brain injury (mTBI) and causes significant distress. Despite extensive research, the etiology of photophobia is poorly understood, and symptoms are difficult to treat. No randomized controlled trials of treatment of photophobia in patients with mTBI exist; however, tinted glasses have been tried with some success. Targeted therapies involving infusion of calcium gene-related peptide antibody may hold promise.
Original language | English (US) |
---|---|
Title of host publication | Controversies in Neuro-Ophthalmic Management |
Subtitle of host publication | An Evidence and Case-Based Appraisal |
Publisher | Springer International Publishing |
Pages | 235-242 |
Number of pages | 8 |
ISBN (Electronic) | 9783030741037 |
ISBN (Print) | 9783030741020 |
DOIs | |
State | Published - Jun 25 2021 |
Keywords
- Concussion
- Mild traumatic brain injury
- Photophobia
- Photosensitivity
- Traumatic brain injury
ASJC Scopus subject areas
- General Medicine